The Wistar Institute Welcomes New Members to Board of Trustees

The Wistar Institute Welcomes New Members to Board of Trustees

February 17, 2012

PHILADELPHIA – (February 22, 2012) – The Wistar Institute recently welcomed two new members, I. Wistar Morris, III and Abraham L. Morris, to its board of trustees.

“With their expertise and leadership, I am confident our new members will complement Wistar's dynamic board of trustees, who are integral to Wistar's success as a leader in cancer research and vaccine development,” said Wistar President and CEO Russel E. Kaufman, M.D.

I. Wistar Morris, a member of the Wistar family, currently serves as senior investment consultant to The Pennsylvania Trust. Morris also served as director and investment advisor for 20 years at Boenning & Scattergood, an investment securities firm, retiring in April 2010.

Prior to The Pennsylvania Trust, Wistar Morris was the founder and director of Morris Investment Management, which was sold to The Pennsylvania Trust in 1997. Morris began his investment career with Elkins Morris and Stroud and later moved to Hopper Soliday where he was responsible for the firm’s investment management business and simultaneously ran the Afuture Fund under a sub-advisory agreement. He also serves on the board of directors for the biotech drug development companies Cempra Pharmaceuticals and Immunome.

Over the past 40 years, Wistar Morris has served on the board of eight non-profit companies including Lankenau Foundation, Mt. Desert and the Academy of Natural Sciences. He is the founder and co-trustee of the Cotswold Foundation and also the author of Adventures in Investing.

Wistar Morris received a bachelor's degree in chemistry from Cornell University, an MBA from the Harvard Business School, and holds the CFA designation from the CFA Institute.

Abraham Morris has over 25 years of business and operational finance experience, including raising over $5 billion in capital, executing global merger and acquisition transactions, and holding various senior corporate management and restructuring positions.

Currently, Abraham Morris serves as co-CEO of Sunlogics, a developer of solar power systems.  Sunlogics is involved in the roll-out of solar charging stations for General Motors as part of its introduction of electric vehicles across the United States.  Prior to Sunlogics, Morris served as lead shareholder representative for Infinia Corporation, a renewable energy and industrial engine technology company, and as President of Aria, an Italian-based wireless broadband technology company.

Previously, Abraham Morris held an appointment as lead shareholder representative at SpinVox, a UK-based voice mail-to-text technology company. And, before joining SpinVox, Morris served as lead shareholder representative for Asprey & Garrard Holdings, an international luxury retail company based in London, England.

Abraham Morris also served as Chief Operating Officer for The Leslie Rudd Investment Company, Senior vice President and Chief Financial Officer of Teligent and Senior Vice President of Operations Support at MFS Communications.

Abraham Morris received a Juris Doctorate with high honors from the National Law Center at The George Washington University and a bachelor’s degree in political science with a concentration in economics from The George Washington University. 

Editors Note: Print-quality photos of Wistar Morris and Abraham Morris are available upon request; contact Alayna Avery at

The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the country, Wistar has long held the prestigious Cancer Center designation from the National Cancer Institute. The Institute works actively to ensure that research advances move from the laboratory to the clinic as quickly as possible. The Wistar Institute: Today’s Discoveries – Tomorrow’s Cures. On the web at